Ofatumumab as Primary Therapy of Chronic Graft Versus Host Disease
Clinical trial NCT01680965 · COMPLETED
Trial details
- NCT number
- NCT01680965
- Sponsor
- H. Lee Moffitt Cancer Center and Research Institute
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-11-14
- Primary completion
- 2020-08-01
- Enrollment
- 44
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.